Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 7, 2012 - Issue 4
Submit an article Journal homepage
16
Views
3
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Oxidative stress and small, dense low-density lipoproteins: current and future perspectives

Ali A Rizvi Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia, SC, USA; Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia, SC, USA
,
Giuseppe Montalto Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy; Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy
,
Angelo Maria Patti Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy; Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy
&
Manfredi Rizzo Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia, SC, USA; Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy; Euro-Mediterranean Institute of Science and Technology, Palermo, Italy. [email protected]; Euro-Mediterranean Institute of Science and Technology, Palermo, Italy. [email protected]
Pages 415-417 | Published online: 10 Jan 2014

References

  • Kotani K, Tsuzaki K, Taniguchi N, Sakane N. LDL particle size and reactive oxygen metabolites in dyslipidemic patients. Int. J. Prev. Med. 3(3), 160–166 (2012).
  • Rizzo M, Berneis K. Who needs to care about small, dense low-density lipoproteins? Int. J. Clin. Pract. 61(11), 1949–1956 (2007).
  • Rizzo M, Berneis K, Corrado E, Novo S. The significance of low-density-lipoproteins size in vascular diseases. Int. Angiol. 25(1), 4–9 (2006).
  • Mikhailidis DP, Elisaf M, Rizzo M et al. European panel on low density lipoprotein (LDL) subclasses: A statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Curr. Vasc. Pharmacol. 9(5), 531–532 (2011).
  • Mikhailidis DP, Elisaf M, Rizzo M et al. ‘European panel on low density lipoprotein (LDL) subclasses’: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr. Vasc. Pharmacol. 9(5), 533–571 (2011).
  • Hirose H, Kawabe H, Komiya N, Saito I. Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J. Atheroscler. Thromb. 16(2), 77–82 (2009).
  • Rizzo M, Kotur-Stevuljevic J, Berneis K et al. Atherogenic dyslipidemia and oxidative stress: a new look. Transl. Res. 153(5), 217–223 (2009).
  • Rizvi AA. Hypertension, obesity, and inflammation: the complex designs of a deadly trio. Metab. Syndr. Relat. Disord. 8(4), 287–294 (2010).
  • Rizvi AA. Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. Am. J. Med. Sci. 338(4), 310–318 (2009).
  • Calkin AC, Cooper ME, Jandeleit-Dahm KA, Allen TJ. Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation. Diabetologia 49(4), 766–774 (2006).
  • Superko HR, Berneis KK, Williams PT, Rizzo M, Wood PD. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A. Am. J. Cardiol. 96(9), 1266–1272 (2005).
  • Mori Y, Itoh Y, Obata T, Tajima N. Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with Type 2 diabetes. Endocrine 29(1), 143–148 (2006).
  • Berneis K, Rizzo M, Stettler C et al. Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes. Expert Opin. Pharmacother. 9(3), 343–349 (2008).
  • Rizzo M, Rini GB, Berneis K. The clinical relevance of LDL size and subclasses modulation in patients with Type-2 diabetes. Exp. Clin. Endocrinol. Diabetes 115(8), 477–482 (2007).
  • Rizzo M, Berneis K, Koulouris S et al. Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with Type 2 diabetes? Int. J. Clin. Pract. 64(12), 1632–1642 (2010).
  • Corrado E, Rizzo M, Muratori I, Coppola G, Novo S. Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or Type II diabetes. Arch. Med. Res. 37(8), 1004–1009 (2006).
  • Rizzo M, Mikhailidis DP. There is more to predicting vascular disease than just established risk factors. Curr. Pharm. Des. 17(33), 3608–3610 (2011).
  • Barbagallo CM, Polizzi F, Severino M et al. ApoE polymorphism in a small Mediterranean island: relationships with plasma lipids, lipoproteins and LDL particle size. Eur. J. Epidemiol. 17(8), 707–713 (2001).
  • Rizzo M, Berneis K, Hersberger M et al. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Hum. Reprod. 24(9), 2286–2292 (2009).
  • Rizzo M, Pernice V, Frasheri A et al. Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clin. Endocrinol. 70(6), 870–875 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.